Envista Holdings (NVST) Cash from Investing Activities (2018 - 2026)
Envista Holdings' (NVST) quarterly Cash from Investing Activities came in at -$68.9 million in Q2 2026, down 682.95% year-on-year from $11.8 million in Q2 2025, and down 344.52% quarter-over-quarter from -$15.5 million in Q4 2025.
Envista Holdings (NVST) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Envista Holdings' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$68.9 million for Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 682.95% year-over-year to -$68.9 million in Q2 2026; TTM through Apr 2026 was -$111.2 million, a 111.01% decrease from a year earlier, with the FY2025 full-year figure at -$51.1 million, up 6.41% from the prior year.
- Cash from Investing Activities slipped to -$68.9 million in Q2 2026 per NVST's latest filing, from -$15.5 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $5.1 million in Q2 2022 and bottomed at -$591.6 million in Q3 2022.
- The 5-year median for Cash from Investing Activities is -$12.6 million (2023), against an average of -$52.6 million.
- Biggest YoY gain for Cash from Investing Activities was 192.73% in 2022; the steepest drop was 3319.65% in 2022.
- Year by year, Cash from Investing Activities stood at -$1.1 million in 2022, then slumped by 1045.45% to -$12.6 million in 2023, then jumped by 41.27% to -$7.4 million in 2024, then tumbled by 109.46% to -$15.5 million in 2025, then slumped by 344.52% to -$68.9 million in 2026.
- Per Business Quant, the three latest NVST Cash from Investing Activities figures stand at -$68.9 million (Q2 2026), -$15.5 million (Q4 2025), and -$9.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 125.34 Bn | 120.12 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.60 Bn | 43.79 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 33.17 Bn | 31.51 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.71 Bn | 30.48 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.12 Bn | 27.46 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.75 Bn | 23.31 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 13.94 Bn | 13.38 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.90 Bn | 13.77 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.06 Bn | 11.00 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Envista Holdings | 4.36 Bn | 3.27 Bn | 390.10 Mn | -68.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -68.90 Mn |
| Apr 3, 2026 | -68.90 Mn |
| Dec 31, 2025 | -15.50 Mn |
| Dec 31, 2025 | -15.50 Mn |
| Sep 26, 2025 | -9.70 Mn |
| Sep 26, 2025 | -9.70 Mn |
| Jun 27, 2025 | -17.10 Mn |
| Jun 27, 2025 | -17.10 Mn |
| Mar 28, 2025 | -8.80 Mn |
| Mar 28, 2025 | -8.80 Mn |
| Dec 31, 2024 | -7.40 Mn |
| Dec 31, 2024 | -7.40 Mn |
| Sep 27, 2024 | -30.60 Mn |
| Sep 27, 2024 | -30.60 Mn |
| Jun 28, 2024 | -5.90 Mn |
| Jun 28, 2024 | -5.90 Mn |
| Mar 29, 2024 | -10.70 Mn |
| Mar 29, 2024 | -10.70 Mn |
| Dec 31, 2023 | -12.60 Mn |
| Dec 31, 2023 | -12.60 Mn |